Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation.

Antoniak S, Cardenas JC, Buczek LJ, Church FC, Mackman N, Pawlinski R.

Cardiology. 2017;136(4):258-268. doi: 10.1159/000452269. Epub 2016 Nov 24.

2.

Emerging pathophysiological roles for fibrinolysis.

Rein-Smith CM, Church FC.

Curr Opin Hematol. 2014 Sep;21(5):438-44. doi: 10.1097/MOH.0000000000000068. Review.

PMID:
24977437
3.

Murine models do not recapitulate the pathophysiology of age-related venous thrombosis in humans.

Cardenas JC, Aleman MM, Wang JG, Whinna HC, Wolberg AS, Church FC.

J Thromb Haemost. 2013 May;11(5):990-2. doi: 10.1111/jth.12189. No abstract available.

4.

Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer.

Wang JG, Geddings JE, Aleman MM, Cardenas JC, Chantrathammachart P, Williams JC, Kirchhofer D, Bogdanov VY, Bach RR, Rak J, Church FC, Wolberg AS, Pawlinski R, Key NS, Yeh JJ, Mackman N.

Blood. 2012 Jun 7;119(23):5543-52. doi: 10.1182/blood-2012-01-402156. Epub 2012 Apr 30.

5.

Mature breast adipocytes promote breast cancer cell motility.

Carter JC, Church FC.

Exp Mol Pathol. 2012 Jun;92(3):312-7. doi: 10.1016/j.yexmp.2012.03.005. Epub 2012 Mar 15.

PMID:
22445926
6.

A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity.

Bompiani KM, Monroe DM, Church FC, Sullenger BA.

J Thromb Haemost. 2012 May;10(5):870-80. doi: 10.1111/j.1538-7836.2012.04679.x.

7.
8.

The controversial role of the urokinase system in abdominal aortic aneurysm formation and rupture.

Rein CM, Cardenas JC, Church FC.

Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2769-71. doi: 10.1161/ATVBAHA.111.237123. No abstract available.

PMID:
22096092
9.

Serpin-glycosaminoglycan interactions.

Rein CM, Desai UR, Church FC.

Methods Enzymol. 2011;501:105-37. doi: 10.1016/B978-0-12-385950-1.00007-9.

PMID:
22078533
10.

Heparin cofactor II: discovery, properties, and role in controlling vascular homeostasis.

Rau JC, Mitchell JW, Fortenberry YM, Church FC.

Semin Thromb Hemost. 2011 Jun;37(4):339-48. doi: 10.1055/s-0031-1276582. Epub 2011 Jul 30. Review.

PMID:
21805439
11.

Regulation of thrombin-induced plasminogen activator inhibitor-1 in 4T1 murine breast cancer cells.

McEachron TA, Church FC, Mackman N.

Blood Coagul Fibrinolysis. 2011 Oct;22(7):576-82. doi: 10.1097/MBC.0b013e3283497647.

PMID:
21799402
12.

Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice.

Machlus KR, Cardenas JC, Church FC, Wolberg AS.

Blood. 2011 May 5;117(18):4953-63. doi: 10.1182/blood-2010-11-316885. Epub 2011 Feb 25.

13.

Protein C inhibitor inhibits factor VIIa when bound to tissue factor.

Fortenberry YM, Hlavacek AC, Church FC.

J Thromb Haemost. 2011 Apr;9(4):861-3. doi: 10.1111/j.1538-7836.2011.04196.x. No abstract available.

14.

Overexpression of the cell cycle inhibitor p16INK4a promotes a prothrombotic phenotype following vascular injury in mice.

Cardenas JC, Owens AP 3rd, Krishnamurthy J, Sharpless NE, Whinna HC, Church FC.

Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):827-33. doi: 10.1161/ATVBAHA.110.221721. Epub 2011 Jan 13.

15.

Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis.

McEachron TA, Pawlinski R, Richards KL, Church FC, Mackman N.

Blood. 2010 Dec 2;116(23):5037-44. doi: 10.1182/blood-2010-06-293126. Epub 2010 Aug 24.

16.

Protein C inhibitor regulates both cathepsin L activity and cell-mediated tumor cell migration.

Fortenberry YM, Brandal S, Bialas RC, Church FC.

Biochim Biophys Acta. 2010 Jun;1800(6):580-90. doi: 10.1016/j.bbagen.2010.03.003. Epub 2010 Mar 15.

PMID:
20230872
17.

Enhanced cell-associated plasminogen activator pathway but not coagulation pathway activity contributes to motility in metastatic breast cancer cells.

Carter JC, Campbell RA, Gibbons JA, Gramling MW, Wolberg AS, Church FC.

J Thromb Haemost. 2010 Jun;8(6):1323-32. doi: 10.1111/j.1538-7836.2010.03825.x. Epub 2010 Feb 24.

18.

"Coagulation proteins with uncertain function".

Church FC.

Thromb Res. 2010 Mar;125(3):203-4. doi: 10.1016/j.thromres.2010.01.016. Epub 2010 Feb 2. No abstract available.

PMID:
20123148
19.

Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment.

Gramling MW, Church FC.

Thromb Res. 2010 May;125(5):377-81. doi: 10.1016/j.thromres.2009.11.034. Epub 2010 Jan 15. Review.

20.

Activated protein C enhances cell motility of endothelial cells and MDA-MB-231 breast cancer cells by intracellular signal transduction.

Gramling MW, Beaulieu LM, Church FC.

Exp Cell Res. 2010 Feb 1;316(3):314-28. doi: 10.1016/j.yexcr.2009.10.024. Epub 2009 Nov 3.

Supplemental Content

Loading ...
Support Center